What is Medigene AG (MDGEF)?

Medigene AG (MDGEF) is a stock in the Healthcare sector, Biotechnology industry. View full analysis on Stocks360.

What is the current price of MDGEF?

The current price of MDGEF is $2.59. Prices are updated in real time on Stocks360.

What is MDGEF's price-to-earnings (PE) ratio?

MDGEF's trailing twelve-month PE ratio is -1.75, based on current price and earnings per share data available on Stocks360.

What is MDGEF's market capitalization?

MDGEF's market capitalization is $38,170,366.00, placing it in the small-cap tier.

Medigene AG (MDGEF)

Stock analysis · OTC · Healthcare · Biotechnology

$2.59

Market Cap

$38.17M

PE (TTM)

-1.75

EPS (TTM)

N/A

Dividend Yield

0.00%

Beta

1.36

Day Range

$0.10 – $2.59

52-wk Range

$0.10 – $2.59

Avg Volume

N/A

Volume

10.00K

Medigene AG (MDGEF) is a publicly traded company in the Healthcare sector. Latest price: $2.59. Market cap $38.17M. Trailing PE -1.75. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

You have viewed 6 SEO analysis pages

Unlock saved watchlists, personalized setups, and referral credits with a free Stocks360 account.

Continue with free signup

1-Year Price

2025-10-31 · $2.59 2026-05-15 · $2.59 (+0.00%)

Earnings

Most Recent

Oct 24, 2024

EPS $-0.56 vs est. $-0.60

Beat by $0.04

Proprietary Signals

Signal snapshot temporarily unavailable.

About Medigene AG

Medigene AG is in the process of liquidation of its remaining assets. Previously, the company was engaged in the development of T-cell therapies for the treatment of cancer. Medigene AG was founded in 1994 and is headquartered in Munich, Germany.

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)	-1.75×
P/S (TTM)	5.64×
P/B	1.35×
P/FCF (TTM)	-2.16×
EV / EBITDA	-1.94×
EV / Sales	4.70×
Earnings Yield	-57.00%
Free Cash Flow Yield	-46.34%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value	$28.33M
Revenue (TTM)	$6.03M
Net Income (TTM)	-$19.41M
Free Cash Flow (TTM)	-$15.25M
Net Debt	-$5.72M
Working Capital	$10.96M
Gross Margin	72.77%
Operating Margin	-267.63%
Net Margin	-268.10%
Return on Equity	-55.69%
Return on Invested Capital	-70.75%